FTC Targets Disclosures, “Up To” And “Doctor-Recommended” Claims
This article was originally published in The Rose Sheet
Executive Summary
“A lot of research casts doubt on the effectiveness of disclosures,” says FTC official Richard Cleland. FTC will also zero in on “up to,” “doctor-recommended” and business-to-business claims, he notes.